Does liquid chromatography-tandem mass spectrometry have a role in therapeutic drug monitoring of digoxin?

Clinical Biochemistry

Volumn 43, Issue 10-11, 2010, Pages 936-937

  Taylor, Paul J ^a   Morris, Raymond G ^b,c  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Digoxin; Liquid chromatography tandem mass spectrometry; Therapeutic drug monitoring

Indexed keywords

ALDOSTERONE; CANRENONE; DIGITALIS LIKE FACTOR; DIGOXIN; DRUG METABOLITE; IMMUNOSUPPRESSIVE AGENT; METADRENALIN; SPIRONOLACTONE; STEROID;

ACCURACY; ANALYTICAL ERROR; CALIBRATION; DRUG MONITORING; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; ISOTOPE DILUTION ASSAY; LABORATORY AUTOMATION; LABORATORY TEST; LETTER; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; NEWBORN SCREENING; PRIORITY JOURNAL; PROCESS DEVELOPMENT; ROBOTICS; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY;

CHROMATOGRAPHY, LIQUID; DIGOXIN; HUMANS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 77953722518     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.04.067     Document Type: Letter

References (19)

1. Valdes R. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications. Clin Chem 1985, 31:1525-1532.
2. Morris R.G., Lagnado P.Y., Lehmann D.R., Frewin D.B., Glistak M.L., Burnet R.B. Spironolactone as a source of interference in commercial digoxin immunoassays. Ther Drug Monit 1987, 9:208-211.
3. Steimer W., Muller C., Eber B. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids. Clin Chem 2002, 48:507-516.
4. Koobatian T.J., Roberts J.R. Falsely elevated serum digoxin levels secondary to endogenous digoxin-like immunoreactive substances. Acad Emerg Med 1995, 2:322-326.
5. Jortani S.A., Valdes R. Digoxin and its related endogenous factors. Crit Rev Clin Lab Sci 1997, 34:225-274.
6. Dasgupta A. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin. Am J Clin Pathol 2002, 118:132-140.
7. Dasgupta A. Therapeutic drug monitoring of digoxin: impact of endogenous and exogenous digoxin-like immunoreactive substances. Toxicol Rev 2006, 25:273-281.
8. Rogers N.M., Jones T.E., Morris R.G. Frequently discordant results from therapeutic drug monitoring for digoxin-clinical confusion for the prescriber. Intern Med J 2010, 40:52-56.
9. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997, 336:525-533.
10. Taylor P.J. High-performance liquid chromatography-mass spectrometry in the clinical laboratory. Ther Drug Monit 2005, 27:689-693.
11. Sahai I., Marsden D. Newborn screening. Crit Rev Clin Lab Sci 2009, 46:55-82.
12. Taylor P.J. Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry. Ther Drug Monit 2004, 26:215-219.
13. Vogeser M., Parhofer K.G. Liquid chromatography tandem-mass spectrometry (LC-MS/MS)-technique and applications in endocrinology. Exp Clin Endocrinol Diabetes 2007, 115:559-570.
14. Li S., Liu G., Jia J., Miao Y., Gu S., Miao P., et al. Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS/MS method. Clin Biochem 2010, 43:307-313.
15. Mitamura K., Horikawa A., Yamane Y., Ikeda Y., Fujii Y., Shimada K. Determination of digoxin in human serum using stable isotope dilution liquid chromatography/electrospray ionization-tandem mass spectrometry. Biol Pharm Bull 2007, 30:1653-1656.
16. Koal T., Deters M., Casetta B., Kaever V. Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 805:215-222.
17. Ceglarek U., Lembcke J., Fiedler G.M., Werner M., Witzigmann H., Hauss J.P., et al. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta 2004, 346:181-190.
18. de Jong W.H., Graham K.S., van der Molen J.C., Links T.P., Morris M.R., Ross H.A., et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clin Chem 2007, 53:1684-1693.
19. Taylor P.J., Cooper D.P., Gordon R.D., Stowasser M. Measurement of aldosterone in human plasma by semi-automated high performance liquid chromatography-tandem mass spectrometry. Clin Chem 2009, 55:1155-1162.